Page last updated: 2024-11-01

norfloxacin and Empyema

norfloxacin has been researched along with Empyema in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Empyema: Presence of pus in a hollow organ or body cavity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castellote, J1
Xiol, J1
Rota Roca, R1
Fernandez Esparrach, G1

Other Studies

1 other study available for norfloxacin and Empyema

ArticleYear
Spontaneous bacterial peritonitis and empyema by Escherichia coli resistant to norfloxacine in a patient on selective intestinal decontamination with norfloxacine.
    Journal of hepatology, 1994, Volume: 20, Issue:3

    Topics: Drug Resistance, Microbial; Empyema; Escherichia coli Infections; Female; Humans; Incidence; Intesti

1994